Skip to content

Clinical trials

Completed Head and Neck Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Status: Completed Country / region: Singapore Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20131
20141
20152
20172
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Centre, Singapore2
Singapore General Hospital2
AstraZeneca1
Bayer1
BeiGene1
Celgene1
Hoffmann-La Roche1
Novartis Pharmaceuticals1
Sanofi1
Tessa Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms12
Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Epstein-Barr Virus Infections2
Nasopharyngeal Carcinoma2
Nasopharyngeal Neoplasms2
Neoplasm Metastasis2
Adenocarcinoma1
Adenocarcinoma of Lung1
Adenocarcinoma, Papillary1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.